TIMOTHY C. RODELL, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GT Biopharma, Inc.

Filing Date Source Excerpt
2004-04-29 Dr. Rodell is Chief Executive Officer of GlobeImmune, Inc., an early stage immunotherapy company.
2005-04-29 Since 2002, Dr. Rodell has served as Chief Executive Officer of GlobeImmune, Inc., an early stage immunotherapy company.

Data sourced from SEC filings. Last updated: 2025-07-01